Pathogenic myeloid phenotypes drive disease pathology in a novel human neurohistiocytosis model
Blood · 23.07.2026 · 148 (4) · 433-449
DOI: 10.1182/blood.2025032207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, erschienen am 23.07.2026. Verfasst von Shivakumar Rajamanickam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of California San Diego, La Jolla, CA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Neurodegenerative Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Innate immunity is increasingly recognized as a driver of neurodegeneration, although pathogenic mechanisms are incompletely understood. Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplastic disorder caused by activating somatic mutations in MAPK pathway genes, most commonly BRAFV600E, in myeloid precursors. A subset of patients with LCH develop progressive neurodegeneration (LCH-ND). We generated a human induced pluripotent stem cell (iPSC) model from patients with somatic hematologic mosaicism for BRAFV600E. Brain macrophages/microglia from LCH iPSCs exhibit unique disease-specific pathogenic features. Stepwise differentiation identified hematopoietic progenitors as hyperproliferative, whereas brain macrophages were apoptosis resistant. Through application of cerebral organoids and a humanized murine xenotransplantation model, we identify marked heterogeneity of differentiation potential within clonal BRAFV600E lines in vivo. This model phenocopied human-specific phenotypes, including dense basal ganglia foci of abnormal macrophages, marked neurodegeneration with astrogliosis, and progressive ataxia. This approach will allow for preclinical testing of therapeutics for LCH-ND.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, University of California San Diego, La Jolla, CA.
- Sanford Consortium for Regenerative Medicine, La Jolla, CA.
- Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
- Division of Pediatric Pathology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
- Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA.
- Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, TX.
ORCID-Profile: Shivakumar Rajamanickam, Samantha Mak, Amanda M Wilpitz, Celina Nguyen, Jennifer Picarsic, Nicole G Coufal
Förderung
- NCI NIH HHS
- NIH HHS
Zitieren
APA
Rajamanickam, S., Trescott, S., Mak, S., Warden, A. S., Wilpitz, A. M., Xia, B., Nguyen, C., Ding, H., Picarsic, J., Glass, C. K., Allen, C. E., & Coufal, N. G. (2026). Pathogenic myeloid phenotypes drive disease pathology in a novel human neurohistiocytosis model. Blood, 148(4), 433-449. https://doi.org/10.1182/blood.2025032207
Vancouver
Rajamanickam S, Trescott S, Mak S, Warden AS, Wilpitz AM, Xia B, et al. Pathogenic myeloid phenotypes drive disease pathology in a novel human neurohistiocytosis model. Blood. 2026;148(4):433-449. doi:10.1182/blood.2025032207
BibTeX
@article{Rajamanickam2026,
author = {Rajamanickam, Shivakumar and Trescott, Samantha and Mak, Samantha and Warden, Anna S and Wilpitz, Amanda M and Xia, Bing and Nguyen, Celina and Ding, Hilda and Picarsic, Jennifer and Glass, Christopher K and Allen, Carl E and Coufal, Nicole G},
title = {Pathogenic myeloid phenotypes drive disease pathology in a novel human neurohistiocytosis model},
journal = {Blood},
year = {2026},
volume = {148},
number = {4},
pages = {433--449},
doi = {10.1182/blood.2025032207}
}
EUVIMED